Summary.-All of 10 patients with colonic carcinoma and 5 with malignant melanoma of skin showed no sign of immunoreactivity against the cultured tumour cells by the lymphocyte populations residing within the tumours. More than half of these patients did show cytotoxic reactivity by their blood lymphocytes. Possible cytotoxic reactivity by the regional lymph node lymphocytes was also investigated in 57 tumour cases (44 colonic, 13 melanoma, and including 12 of the 15 examined for intrinsic lymphocyte activity). One third of the cases showed positive blood lymphocyte immunoreactivity, but in only 4 tumours (3 colonic) did the node lymphocytes show any cytotoxicity against the tumour cells. This state of anergy of intrinsic and regional lymphocytes is presumably acquired during the development of the cancer and would permit local tumour spread and metastasis to lymph nodes. Its cause has not been identified but appears to be lymphocyte inhibition rather than selective change in lymphocyte population. In particular, no special pattern can be seen in the relative proportions of T and B cells in patients' blood, lymph node or intrinsic carcinoma lymphocytes.
IN earlier reports of immunological reactivity in patients with carcinoma of colon (Nairn et al., 1971a) , and squamous cell carcinoma and malignant melanoma of skin (Nairn et al., 1971b Nairn, 1972) , we observed that lymphocytes from the carcinoma itself or from regional lymph nodes were not cytotoxic against cultured tumour cells even though the patients' blood lymphocytes often were cytotoxic. Continued work has elaborated these preliminary observations and we have studied the phenomenon more deeply by analysing and varying, by cell fractionation procedures, the intrinsic lymphocyte populations of the carcinomata before culture. T and B cell proportions in the different lymphoid preparations have been assessed by membrane immunofluorescence and show no apparent correlation with lymphocyte cytotoxicity.
MATERIALS AND METHODS
Tumour and blood collection, preparation of cell suspensions, freeze storage, inhibition of microbial growth, and culture of carcinoma cells for detecting cytotoxic activity of the patient's lymphocytes were all performed by the same techniques as in the earlier studies cited above.
For the investigation of intrinsic lymphocyte reactivity, 10 cases of colonic carcinoma and 5 of malignant melanoma of skin (2 metastatic) were selected only insofar as they were the first tumours received providing sufficient carcinoma cells and lymphocytes for the investigations. For most tests, the cells from the carcinoma wAere used fresh.
Frozen cells preserved with dimethylsulphoxide in liquid nitrogen were used only when we were assured that this w%ould not interfere with assessment of comparative tumour growth in culture. For the testing of possible interaction between intrinsic lymphocytes and blood or lymph node lymphocytes, the majority of blood and lymph node preparations were also used fresh for culture; only 1 lymphocyte specimen from blood and 3 from lymph node, all colonic cases, were freeze stored before use. The lymph nodes and blood lymphocytes were obtained about the time of operation, except for Case 6 in which blood lymphocytes were obtained 6 and 10 weeks later.
For the investigation of regional lymph node lymphocyte reactivity, 57 tumours were examined: 44 were colonic carcinomata (1 metastatic in liver) and 13 skin melanomata (4 metastatic in lymph node, 2 in brain), including all the cases in Table I except 3, 14. 15. In 31 cases, the lymphocytes were used fresh wvithout prior freezing and the majority of the parallel blood lymphocyte cytotoxicity studies were also made with fresh cells (frozen-thawed blood lymphocytes were used in 11 colonic cases only). In 5 cases, the fresh blood lymphocytes were not available until some weeks after the operation but none were used beyond 20 weeks. Persistence of the patient's lymphocyte reactivity for several months after tumour resection has been established in our earlier and present studies. We were unable to test blood lymphocyte reactivity in 6 of the colonic carcinomata.
Spleen cell reactivity was investigated in 3 cases. Two were post mortem melanomata (12b, 13) and one a metastatic colonic carcinoma in liver (72/158- Table III) .
Tumour cell fractionation to alter intrinsic lymphocytosis-.For this investigation, the 15 tumour cell suspensions plus 3 additional preparations from further specimens of 2 of the melanoma cases (11 and 12- Table I) were passed successively through and eluted from 2 sterile glass bead columns (modified from Shortman, 1966) to change the proportion of lymphocytes to carcinoma cells in the effluents. Samples of each effluent were kept for culture and wherever possible for T and B lymphocyte analysis. The columns were made from 5 ml plastic syringe barrels with the nozzle lightly plugged with glass wool and fitted with a No. 22 Luer hypodermic needle; they contained 2 ml of glass beads of 60-90 ,um diameter. The original tumour cell suspension was gently washed 3 times in medium 199 containing 10bo foetal calf serum with centrifuging at 250 g maximum for 5 min periods. It was adjusted to a concentration of 3-10 million cells per ml, and 5 ml of this suspension was passed through a glass bead column previously rinsed with medium 199 containing 10% foetal calf serum: this yielded fraction 1. The beads were then removed from the column and rinsed twice with 10 ml of the same medium to give fraction 2. Of this, 15-25 million cells were recovered by centrifuging and resuspended in 5 ml medium 199 containing 5000, foetal calf serum and passed through a column previouslv rinsed Mwith the same solution.
This yielded fraction 3, and two 10 ml washings of the beads with the same medium, fraction 4. cells were enumerated and the T cells assessed by difference. Accurate counting necessitated the recognition and ignoring of non-lymphoid cells usually unstained but occasionally stained nonspecifically, as in the case of granulocytes. These were largely removed from blood and fractionated carcinoma by their adherence to the glass w-ool and beads to which th-ey were respectively exposed; unfractionated carcinoma cell suspensions contained only a few granulocytes and the lymplh node preparations virtually none. blood lymphocytes. Six tests were made with non-cross-reacting homologous lymphocytes against colonic carcinoma (4) and melanoma (2) fractions without any change in reactivity. Lymph node lymphocyte reactivity with tumour fractions (Table II) was tested in 2 colonic carcinomata (Cases 4, 7) and 2 specimens of 1 melanoma (lla,b). In Case 4, all fractions were tested, in 7 and 11 a only fraction 1, and in 11 b fraction 2. Reactivity against the colonic carcinomata was negative and unchanged with the fractions; against the melanoma specimens it was positive and also unchanged with the fractions.
Lymph node lymphocytes
Only 4 of the 57 tumours examined showed reactivity by the regional lymph node lymphocytes (Table II) (Table  II) : 4 were with colonic carcinomata and 2 melanomata, none being from the cases recorded in Table I . One of the colonic and 1 melanoma case were blood lymphocyte-positive; they were all lymph node lymphocyte-negative. For these tests, the blood and lymph node lymphocytes were added to the tumour culture chambers in equal numbers to give the usual lymphocyte to tumour cell ratio of 2-5: 1. There was no sign of any effect by lymph node lymphocytes on the alreadv known blood lymphocyte reactivity.
In 11 of the cases (9 colonic), lymph 113 nodes distant from the tumour were also examined (Table II ). The lymphocytes were tested fresh except in 4 of the colonic carcinomata where they were frozenthawed. Both of the melanoma cases and 1 colonic were blood lymphocyte-positive; another colonic carcinoma (Case 6) was blood lymphocyte-positive later and had positive regional (near) node lymphocyte reactivity. Blood and regional node lymphocyte reactivities were negative in the other cases. In all 11 cases, the distant node lymphocytes were non-reactive.
T and 13 cell counts were made on 25 of the regional lymph nodes, on 16 of the associated tumours and on 1 2 of the relevant blood samples and 7 of the distant nodes. The findings in the 1 6 cases in which both regional lymph node and tumour were examined are summarized in Table III . It will be seen that except in Tumour infiltration by lymphocytes has been reported as a favourable prognostic feature in breast (Hamlin, 1968) and melanoma (Thompson, 1972) though other studies have failed to observe any such correlation (Williams and Roberts, 1968; Little, 1972 (Currie and Basham, 1972) . Blocking reactivity of sera from our cases has not yet been investigated, but detection of antibodies against tumour cell membrane and cytoplasm (Rolland et al., to be published) correlated poorly with lymphocyte cytotoxicity. Studies on an experimental animal tumour system in our laboratories have demonstrated inhibitory activity in sera from animals bearing advanced tumours at a time when regional lymph nodes were anergic despite persistent blood and spleen lymphocyte cytotoxicity (Flannery et al., 1973) . This is presumably due to prolonged exposure of local lymphocytes to relatively high concentrations of soluble antigen, causing a specific immunological paralysis (Alexander, 1970; Baldwin, Price and Robins, 1 
972).
WNThatever the cause of the local lymphocyte anergy, the phenomenon is presumably highly significant biologically and may be the explanation of tumour spread and regional metastasis despite local abundance of lymphocytes. It will be of great interest to examine, wherever clinically permissible, lymph nodes from the tumour drainage area some months after tumour resection to see if the anergic state may be reversed.
